C
Carol E. Golin
Researcher at University of North Carolina at Chapel Hill
Publications - 242
Citations - 9917
Carol E. Golin is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Psychological intervention & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 46, co-authored 231 publications receiving 8905 citations.
Papers
More filters
Journal ArticleDOI
A Decision Aid to Promote Appropriate Colorectal Cancer Screening among Older Adults: A Randomized Controlled Trial
Carmen L. Lewis,Christine E. Kistler,Alexandra F. Dalton,Carolyn B. Morris,Renee Ferrari,Colleen Barclay,Noel T. Brewer,Rowena J. Dolor,Russell Harris,Maihan Vu,Carol E. Golin +10 more
TL;DR: A PtDA for older adults promoted appropriate CRC screening behavior and intent in a double-blinded randomized controlled trial targeted to older adults making decisions about whether to undergo CRC screening.
Journal ArticleDOI
MACH14: A Multi-Site Collaboration on ART Adherence Among 14 Institutions
Honghu Liu,Ira B. Wilson,Kathy Goggin,Nancy R. Reynolds,Jane M. Simoni,Carol E. Golin,Marc I. Rosen,Robert E. Gross,Glenn J. Wagner,Robert H. Remien,Neil Schneiderman,Judith A. Erlen,Julia H. Arnsten,David R. Bangsberg +13 more
TL;DR: An overview of the design and implementation of MACH14, a collaborative, multi-site study in which a large data system has been created for integrated analyses by pooling original data from 16 longitudinal ARV adherence studies, is provided.
Journal ArticleDOI
Borderline Personality Disorder Symptom Severity and Sexually Transmitted Infection and HIV Risk in African American Incarcerated Men.
Joy D. Scheidell,Carl W. Lejuez,Carol E. Golin,Marcia M. Hobbs,David A. Wohl,Adaora A. Adimora,Maria R. Khan +6 more
TL;DR: Borderline personality disorder symptoms most associated with STI/HIV risk were abandonment worry, mood swings, and shifts in opinions.
Journal ArticleDOI
Using Pharmacies in a Structural Intervention to Distribute Low Dead Space Syringes to Reduce HIV and HCV Transmission in People Who Inject Drugs.
Christine U. Oramasionwu,Terence L. Johnson,William A. Zule,Jessica Carda-Auten,Carol E. Golin +4 more
TL;DR: This work explored using pharmacies in a structural intervention to increase the uptake of low dead space syringes as part of a comprehensive strategy to reverse these epidemics.
Journal ArticleDOI
What's Important to the Patient? Informational Needs of Patients Making Decisions About Hepatitis C Treatment.
Donna M. Evon,Carol E. Golin,Teodora Stoica,Rachel E. Jones,Sarah J. Willis,Joseph A. Galanko,Michael W. Fried +6 more
TL;DR: Patients weighed several informational topics to make an informed decision about HCV treatment to lay the groundwork for future patient-centered outcomes research in HCV and patient-provider communication to enhance patients’ informed decision making regarding direct-acting antiviral treatment options.